These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22722932)

  • 1. Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.
    Hudson RP; Chong PA; Protasevich II; Vernon R; Noy E; Bihler H; An JL; Kalid O; Sela-Culang I; Mense M; Senderowitz H; Brouillette CG; Forman-Kay JD
    J Biol Chem; 2012 Aug; 287(34):28480-94. PubMed ID: 22722932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization.
    Chong PA; Farber PJ; Vernon RM; Hudson RP; Mittermaier AK; Forman-Kay JD
    J Biol Chem; 2015 Sep; 290(38):22862-78. PubMed ID: 26149808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Binding of the Corrector VX-809 to Human CFTR NBD1: Evidence of an Allosteric Coupling between the Binding Site and the NBD1:CL4 Interface.
    Hudson RP; Dawson JE; Chong PA; Yang Z; Millen L; Thomas PJ; Brouillette CG; Forman-Kay JD
    Mol Pharmacol; 2017 Aug; 92(2):124-135. PubMed ID: 28546419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.
    Lewis HA; Zhao X; Wang C; Sauder JM; Rooney I; Noland BW; Lorimer D; Kearins MC; Conners K; Condon B; Maloney PC; Guggino WB; Hunt JF; Emtage S
    J Biol Chem; 2005 Jan; 280(2):1346-53. PubMed ID: 15528182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis.
    Wang C; Protasevich I; Yang Z; Seehausen D; Skalak T; Zhao X; Atwell S; Spencer Emtage J; Wetmore DR; Brouillette CG; Hunt JF
    Protein Sci; 2010 Oct; 19(10):1932-47. PubMed ID: 20687163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric coupling between the intracellular coupling helix 4 and regulatory sites of the first nucleotide-binding domain of CFTR.
    Dawson JE; Farber PJ; Forman-Kay JD
    PLoS One; 2013; 8(9):e74347. PubMed ID: 24058550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
    Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
    Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.
    Gong X; Ahner A; Roldan A; Lukacs GL; Thibodeau PH; Frizzell RA
    J Biol Chem; 2016 Jan; 291(4):2004-2017. PubMed ID: 26627832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
    Scott-Ward TS; Amaral MD
    FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding F508del misfolding in cystic fibrosis.
    Wang XR; Li C
    Biomolecules; 2014 May; 4(2):498-509. PubMed ID: 24970227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.
    Rabeh WM; Bossard F; Xu H; Okiyoneda T; Bagdany M; Mulvihill CM; Du K; di Bernardo S; Liu Y; Konermann L; Roldan A; Lukacs GL
    Cell; 2012 Jan; 148(1-2):150-63. PubMed ID: 22265408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.
    Ehrhardt A; Chung WJ; Pyle LC; Wang W; Nowotarski K; Mulvihill CM; Ramjeesingh M; Hong J; Velu SE; Lewis HA; Atwell S; Aller S; Bear CE; Lukacs GL; Kirk KL; Sorscher EJ
    J Biol Chem; 2016 Jan; 291(4):1854-1865. PubMed ID: 26627831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
    Pissarra LS; Farinha CM; Xu Z; Schmidt A; Thibodeau PH; Cai Z; Thomas PJ; Sheppard DN; Amaral MD
    Chem Biol; 2008 Jan; 15(1):62-9. PubMed ID: 18215773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.
    Liu J; Bihler H; Farinha CM; Awatade NT; Romão AM; Mercadante D; Cheng Y; Musisi I; Jantarajit W; Wang Y; Cai Z; Amaral MD; Mense M; Sheppard DN
    Br J Pharmacol; 2018 Apr; 175(7):1017-1038. PubMed ID: 29318594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.
    Chong PA; Kota P; Dokholyan NV; Forman-Kay JD
    Cold Spring Harb Perspect Med; 2013 Mar; 3(3):a009522. PubMed ID: 23457292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.
    Chan KW; Csanády L; Seto-Young D; Nairn AC; Gadsby DC
    J Gen Physiol; 2000 Aug; 116(2):163-80. PubMed ID: 10919864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.